mesothelioma asbestos cancer treatment unconventional therapy therapies antineoplastons cancell entelev cantron

Mesothelioma Types Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Malignant Mesothelioma, Cystic Mesothelioma, Abdominal Mesothelioma, Chrysotile Peritoneal Mesothelioma, Epithelial Malignant Mesothelioma, Benign Multicystic Mesothelioma, Causes of Mesothelioma, Mesothelioma Asbestosis, Mesothelioma Cancer, Mesothelioma Claim, Mesothelioma Compensation, Mesothelioma Cure, Mesothelioma Diagnosis, Mesothelioma Help, Mesothelioma Information, Mesothelioma Injury, Mesothelioma Law, Law Suit, Attorney, Litigation, Patient, Settlement, Statistics, Support, Symptoms, Mesothelioma Treatment - Angiogenesis Therapies, Optional Drug Therapies, Multimodal Therapies, Photodynamic Therapy, Radiation Therapy, Surgery, Unconventional Therapies, Immunotherapy & Gene Therapy

Mesothelioma Treatment Options - Unconventional Treatments

A number of mesothelioma treatments are outside the mainstream of both established and experimental therapies. As lawyers, not doctors, we are not qualified to judge the value of such unconventional or unproven treatments. In our experience, most doctors disapprove of these treatments, and there is no clear, non-anecdotal evidence of the success of any of these treatments. However, we believe you have the right to all the information available so that you can discuss all possibilities with your physician and make an informed decision about your options.

Antineoplastons: Dr. Stanislaw Burzynski has been working on antineoplastons as a treatment for cancer since 1967. Antineoplastons are naturally occurring peptides which Dr. Burzynski claims can "reprogram" cancerous cells to behave like "normal" cells again. The success of antineoplaston treatments has been highly controversial, however. The American Cancer Society reports that they have no reliable evidence of the objective benefits of antineoplastons. Dr. Burzynski was also charged in 1995 with fraud and violation of Federal Drug Administration regulations. The Burzynski Research Institute is currently conducting clinical trials of antineoplastons.